As of February 2022, subscribers can view and filter individual regulatory alerts per region. If you want to get our monthly compilations, visit our alerts round-up section.
3rd February 2023
3rd February 2023
2nd February 2023
1st February 2023
31st January 2023
US - general: A North Carolina federal judge has ruled that RJ Reynolds Vapor must pay ongoing royalties to Altria for a pod-style vape, after a $95m verdict last year found it was guilty of a patent infringement. The opinion reduces Altria’s demand from 10.5% to 5.25%, which Reynolds will have to pay quarterly until the last of Altria’s patents expires in April 2035. “Altria has not shown that the pod patents’ contribution to the Alto’s performance since May 2019 justifies increasing the jury’s royalty rate of 5.25%,” the judge wrote.
30th January 2023
26th January 2023
25th January 2023
24th January 2023
US - Federal: The Food and Drug Administration (FDA) has denied RJ Reynolds Vapor Company permission to continue selling two menthol e-cigarette products in the US. The agency issued marketing denial orders (MDOs) today against the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%. Brian King, director of the FDA’s Center for Tobacco Products (CTP), said: “The applications for these products did not present sufficient scientific evidence to show that the potential benefit to adult smokers outweighs the risks of youth initiation and use.”
24th January 2023
23rd January 2023
US - general: A US district judge has granted Juul Labs preliminary court approval of a $255m settlement resolving claims by consumers that it deceptively marketed e-cigarettes, Reuters reports. Judge William Orrick said the deal to settle almost 10,000 lawsuits filed by local governments across the US seemed “fair and reasonable.” He must still give final approval to the deal.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.